[The interaction of antiarrhythmic drugs with other drugs].
Yamaguchi
I
I
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000638:Amiodarone / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D004077:Digoxin / Q000378:metabolism / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology; D008801:Mexiletine / Q000378:metabolism / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000378:metabolism / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D008801:Mexiletine; D010672:Phenytoin; D004077:Digoxin; D008012:Lidocaine; D011802:Quinidine; D011342:Procainamide; D000638:Amiodarone